Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients with chronic kidney disease (NU-FLASH trial for CKD)

Abstract Background The NU-FLASH trial demonstrated that febuxostat was more effective for hyperuricemia than allopurinol. This time, we compared these medications in patients with chronic kidney disease (CKD) from the NU-FLASH trial. Methods and results In the NU-FLASH trial, 141 cardiac surgery pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cardiology 2015-10, Vol.66 (4), p.298-303
Hauptverfasser: Sezai, Akira, MD, PhD, Soma, Masayoshi, MD, PhD, Nakata, Kin-ichi, MD, PhD, Osaka, Shunji, MD, PhD, Ishii, Yusuke, MD, Yaoita, Hiroko, MD, Hata, Hiroaki, MD, PhD, Shiono, Motomi, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!